https://www.selleckchem.com/pr....oducts/Nicotinamide(
2 and 3.4-fold increased risk of having CVD or CAD, respectively, as compared to those without NAFLD. Similarly, subjects with prediabetes and NAFLD showed an increased risk of having CVD or CAD by 2.3- and 2.0-fold, respectively, in comparison to their counterpart without NAFLD. Within the group with type 2 diabetes, subjects having NAFLD displayed a 2.3- and 2.0-fold higher risk of having CVD or CAD, respectively, in comparison to those without NAFLD. CONCLUSIONS Ultrasonography-defined NAFLD is independently associa
Like
Comment
Share
